Enterprise Value

492.7M

Cash

329.4M

Avg Qtr Burn

-9.02M

Short % of Float

2.51%

Insider Ownership

8.45%

Institutional Own.

87.37%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date